MARKET

NXLIW

NXLIW

Nexalin Tech
NASDAQ
0.1750
-0.0070
-4.00%
Opening 09:30 02/08 EST
OPEN
--
PREV CLOSE
0.1750
HIGH
--
LOW
--
VOLUME
7
TURNOVER
1
52 WEEK HIGH
0.4000
52 WEEK LOW
0.1000
MARKET CAP
--
P/E (TTM)
-0.7869
1D
5D
1M
3M
1Y
5Y
BRIEF-Nexalin Technology Plans To Present GEN-2 And GEN-3 To FDA For Treatment Of Anxiety And Insomnia
Reuters · 01/05 15:15
Nexalin Technology CEO Provides Letter To Shareholders
Benzinga · 01/05 13:37
About NXLIW
Nexalin Technology, Inc. is engaged in designing and developing neurostimulation products for mental health epidemic. The Company has developed an easy-to-administer medical device, Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. It is also designing clinical trials for the use of Gen-2 for the treatment of substance use disorders and particularly substance abuse issues related to opiates, chronic pain, Alzheimer’s disease and dementia. The Company's products are non-invasive and undetectable and can provide relief to those afflicted with mental health issues without adverse side effects. Its design of varying voltages, currents, electromagnetic fields and various frequencies called as waveform. The Company’s devices generate a high frequency, charge balanced electrical current waveform that is applied to an array of electrodes on the head.

Webull offers kinds of Nexalin Technology Inc stock information, including NASDAQ:NXLIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NXLIW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NXLIW stock methods without spending real money on the virtual paper trading platform.